Clinical Trial Update: Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Biphasic Insulin Aspart 30 to Insulin Glargine, each in combination with metformin and glimepiride, in adults with type 2 diabetes; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)
• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2010-01-06